(PDF) Correction: A Phase I Trial of LY2510924, a CXCR4

Correction: A Phase I Trial of LY2510924, a CXCR4 Peptide Antagonist, in Patients With Advanced Cancer

Clinical Cancer Research - United States

doi 10.1158/1078-0432.ccr-14-1611

Full Text

Abstract

Available in full text

Categories

Cancer Research

Date

August 13, 2014

Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Phase I Clinical Trial of Multiple-Peptide Vaccination for Patients With Advanced Biliary Tract Cancer

Journal of Translational Medicine

Molecular Biology

English

A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine for Patients With Advanced Pancreatic Cancer

Journal of immunotherapy (Hagerstown, Md. : 1997)

Cancer Research

English

A Phase I Trial of Combination Trastuzumab, Lapatinib, and Bevacizumab in Patients With Advanced Cancer

Investigational New Drugs

English

Erratum To: Phase I Clinical Trial of Vaccination With URLC10-derived Peptide for Patients With Advanced Esophageal Cancer

Gastroenterology

English

A Phase I Trial of Temsirolimus and Pemetrexed in Patients With Advanced Non-Small Cell Lung Cancer

Infectious Diseases

English

A Phase I Trial of Combined Ridaforolimus and MK-2206 in Patients With Advanced Malignancies

Clinical Cancer Research

Cancer Research

English

A Phase Ib and Pharmacokinetic Trial of Patupilone Combined With Carboplatin in Patients With Advanced Cancer

Clinical Cancer Research

Cancer Research

English

Phase I Clinical Trial of a Peptide Vaccine Combined With Tegafur-Uracil Plus Leucovorin for Treatment of Advanced or Recurrent Colorectal Cancer

Oncology Reports

Cancer Research

English

Phase I Study of Temozolomide in Paediatric Patients With Advanced Cancer

British Journal of Cancer

Cancer Research

English